Drug-antacid interactions: assessment of clinical importanceD'ARCY, P. F; MCELNAY, J. C.Drug intelligence & clinical pharmacy. 1987, Vol 21, Num 7-8, pp 607-617, issn 0012-6578, 1Article

Compatibility study between famotidine and some excipients using differential scanning calorimetryGUNAWAN INDRAYANTO; MUGIHARDJO; RATNA HANDAYANI et al.Drug development and industrial pharmacy. 1994, Vol 20, Num 5, pp 911-920, issn 0363-9045Article

The investigation of the influence of sodium hexametaphosphate on the dissolution rate of antacidsKOKOT, Z.Pharmazie. 1989, Vol 44, Num 10, issn 0031-7144, 724 [1 p.]Article

Molecular behavior of flufenamic acid in physical and ground mixtures with floriteALI, A. S; YAMAMOTO, K; EL-SAYED, A. M et al.Chemical and pharmaceutical bulletin. 1992, Vol 40, Num 5, pp 1289-1294, issn 0009-2363Article

Complexes à multicomposants de miconazole avec différents acides et cyclodextrines = Multicomponent complexes of miconazole with different acidsPIEL, G; EVRARD, B; DELATTRE, L et al.Journal de pharmacie de Belgique. 1997, Vol 52, Num 3, issn 0047-2166, p.124Article

Antioxidantieneinflüsse auf den Zersetzungsmechanismus des Epinephrins = Effects of antioxidants on degradation mechanism of epinephrine solutionsRAETHER, G; LIEBUS, F; KLOPSCH, D et al.Pharmazie. 1991, Vol 46, Num 6, pp 426-431, issn 0031-7144, 6 p.Article

Wechselwirkungen zwischen makromolekularen Hilfsstoffen und Arzneistoffen. XXVIII: Beeinflussung der Auflösungscharakteristika von Chloramphenicol durch Stärkederivate = Interactions entre adjuvants macromoléculaires et médicaments. 28: Influence des dérivés d'amidon sur la dissolution du chloramphénicol = Interactions between macromolecular adjuvants and drugs. Part 28: the influence of starch derivates on dissolution characteristics of chloramphenicolKEIPERT, S; HILDEBRANDT, S.Pharmazie. 1990, Vol 45, Num 2, pp 111-116, issn 0031-7144Article

Effects of some hydrophilic permeation enhancers on the absorption of bepridil through excised human skinKLAMERUS, K; LEE, G.Drug development and industrial pharmacy. 1992, Vol 18, Num 13, pp 1411-1422, issn 0363-9045Article

A fluorimetric, potentiometric and conductimetric study of the aqueous solutions of naproxen and its association with hydroxypropyl-β-cyclodextrinJUNQUERA, E; AICART, E.International journal of pharmaceutics. 1999, Vol 176, Num 2, pp 169-178, issn 0378-5173Article

LES PHOSPHATES DE CALCIUM, SUPPORTS POTENTIELS DE MEDICAMENTS IMPLANTABLES : ETUDE DE LEURS MECANISMES DE DISSOLUTION ET D'ADSORPTION = CALCIUM PHOSPHATES AS CARRIERS FOR DRUG SLOW RELEASE : STUDY OF THEIR DISSOLUTION AND ADSORPTION MECHANISMSSallek, Brahim; Lebugle, Albert.1993, 164 p.Thesis

Monitoring indomethacin/adjuvant interactions using high pressure liquid chromatography and ultraviolet spectroscopyISMAIL, F. A; KHALAFALLA, N. M; KHALIL, S. A et al.S.T.P. pharma sciences. 1992, Vol 2, Num 4, pp 342-346Article

Effect of additives on dissolution characteristics of furosemide-polyvinylpyrrolidone solid-dispersion systemsAKBUGA, J.Pharmazeutische Industrie. 1991, Vol 53, Num 9, pp 857-860, issn 0031-711XArticle

Use of chemical enhancers for nasal drug deliveryDE PONTI, R; LARDINI, E.Drug development and industrial pharmacy. 1991, Vol 17, Num 11, pp 1419-1436, issn 0363-9045Article

Einsatzmöglichkeiten von Betamethasonacetat-Modifikationen für wäβrige suspensionen. II, Mitteilung = Operational possibilities of betamethasone-acetate modifications in aqueous suspensions/2nd commSEILLER, V. E; NÜRNBERG, E.Pharmazeutische Industrie. 1990, Vol 52, Num 1, pp 104-107, issn 0031-711X, 4 p.Article

Influence of egg albumin on dissolution of several drupsIMAI, I; SAITO, Y; MATSUMOTO, H et al.International journal of pharmaceutics. 1989, Vol 53, Num 1, pp 7-12, issn 0378-5173Article

Acute and long-term stability studies of deoxy hemoglobin and characterization of ascorbate-induced modificationsKERWIN, B. A; AKERS, M. J; SCHUBERT, R et al.Journal of pharmaceutical sciences. 1999, Vol 88, Num 1, pp 79-88, issn 0022-3549Article

Solubility, ¹H-NMR, and molecular mechanics of mebendazole with different cyclodextrinsDIAZ, D; BERNAD, M. J. B; GRACIA-MORA, J et al.Drug development and industrial pharmacy. 1999, Vol 25, Num 1, pp 111-115, issn 0363-9045Article

Surfactant mediated effects in pressurized metered dose inhalers formulated as suspensions. I: Drug/surfactant interactions in a model propellant systemCLARKE, J. G; WICKS, S. R; FARR, S. J et al.International journal of pharmaceutics. 1993, Vol 93, Num 1-3, pp 221-231, issn 0378-5173Article

Interactions of oxyphenbutazone with polyvinylpyrrolidoneMORTADA, L. M; BOSTANIAN, L. A; SALIB, N. N et al.Pharmazie. 1990, Vol 45, Num 5, pp 350-353, issn 0031-7144, 4 p.Article

Variable effects oif laurocapram (Azone) on rectal cefoxitin absorption in ratsVAN HOOGDALEM, E. J; DE BEST, M. A; DE BOER, A. G et al.Journal of pharmaceutical sciences. 1989, Vol 78, Num 8, pp 691-692, issn 0022-3549Article

Theoretical study of metronidazole adsorption on clinoptiloliteLAM, A; RIVERA, A; RODRIDGUEZ-FUENTES, G et al.Microporous and mesoporous materials. 2001, Vol 49, Num 1-3, pp 157-162, issn 1387-1811Article

Compatibility of medications with 3-in-1 parenteral nutrition admixturesTRISSEL, L. A; GILBERT, D. L; MARTINEZ, J. F et al.JPEN. Journal of parenteral and enteral nutrition. 1999, Vol 23, Num 2, pp 67-74, issn 0148-6071Article

Lisinopril-lactose incompatibilityEYJOLFSSON, R.Drug development and industrial pharmacy. 1998, Vol 24, Num 8, pp 797-798, issn 0363-9045Article

A thermal analysis study of ascorbic acid and its pharmaceutical formulations : A consideration of time-temperature plotsLERDKANCHANAPORN, S; DOLLIMORE, D; ALEXANDER, K. S et al.Journal of thermal analysis. 1997, Vol 49, Num 2, pp 887-896, issn 0368-4466Article

The effects of pharmaceutical excipients on small intestinal transitADKIN, D. A; DAVIS, S. S; SPARROW, R. A et al.British journal of clinical pharmacology. 1995, Vol 39, Num 4, pp 381-387, issn 0306-5251Article